Goldman Sachs Group Reiterates Buy Rating for Informa (INF)
Informa (LON:INF)‘s stock had its “buy” rating reissued by research analysts at Goldman Sachs Group in a research report issued to clients and investors on Monday. They currently have a GBX 849 ($11.09) price objective on the stock, down from their prior price objective of GBX 991 ($12.95). Goldman Sachs Group’s price target indicates a potential upside of 31.75% from the company’s previous close.
A number of other equities analysts also recently commented on INF. Barclays decreased their target price on Informa from GBX 940 ($12.28) to GBX 885 ($11.56) and set an “overweight” rating for the company in a research note on Friday, September 28th. Citigroup upgraded Informa to a “buy” rating in a research note on Friday, September 28th. Shore Capital restated a “buy” rating on shares of Informa in a research note on Tuesday, October 2nd. JPMorgan Chase & Co. lifted their target price on Informa from GBX 803 ($10.49) to GBX 812 ($10.61) and gave the company a “neutral” rating in a research note on Friday, October 5th. Finally, Peel Hunt restated a “hold” rating on shares of Informa in a research note on Monday, October 8th. Four equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of GBX 858.42 ($11.22).
Shares of INF stock opened at GBX 644.40 ($8.42) on Monday. Informa has a 52 week low of GBX 624.50 ($8.16) and a 52 week high of GBX 773 ($10.10).
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Further Reading: Cost of Debt
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.